Cargando…
A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host
Chemical synthesis of conjugate vaccines, consisting of a polysaccharide linked to a protein, can be technically challenging, and in vivo bacterial conjugations (bioconjugations) have emerged as manufacturing alternatives. Bioconjugation relies upon an oligosaccharyltransferase to attach polysacchar...
Autores principales: | Harding, Christian M., Nasr, Mohamed A., Scott, Nichollas E., Goyette-Desjardins, Guillaume, Nothaft, Harald, Mayer, Anne E., Chavez, Sthefany M., Huynh, Jeremy P., Kinsella, Rachel L., Szymanski, Christine M., Stallings, Christina L., Segura, Mariela, Feldman, Mario F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385209/ https://www.ncbi.nlm.nih.gov/pubmed/30792408 http://dx.doi.org/10.1038/s41467-019-08869-9 |
Ejemplares similares
-
Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines
por: Price, Nancy L., et al.
Publicado: (2016) -
A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae
por: Feldman, Mario F., et al.
Publicado: (2019) -
Development and Immunogenicity of a Prototype Multivalent
Group B Streptococcus Bioconjugate Vaccine
por: Duke, Jeremy A., et al.
Publicado: (2021) -
Treatment of Pneumonia by a Polyvalent Stock Pneumococcic Vaccine
por: Charteris, Frank
Publicado: (1912) -
Rewiring the pneumococcal capsule pathway for investigating glycosyltransferase specificity and genetic glycoengineering
por: Su, Tong, et al.
Publicado: (2023)